SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-21-003811
Filing Date
2021-03-31
Accepted
2021-03-31 15:57:15
Documents
110
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K jagx-20201231x10k.htm 10-K 3507589
2 EX-10.24 jagx-20201231ex10249f535.htm EX-10.24 196627
3 EX-10.67 jagx-20201231ex1067a0135.htm EX-10.67 294807
4 EX-23.1 jagx-20201231ex2318ff26e.htm EX-23.1 6267
5 EX-31.1 jagx-20201231ex31113ab28.htm EX-31.1 9707
6 EX-31.2 jagx-20201231ex31278d8f5.htm EX-31.2 9957
7 EX-32.1 jagx-20201231ex321aeb636.htm EX-32.1 5276
8 EX-32.2 jagx-20201231ex322f0775a.htm EX-32.2 6035
9 GRAPHIC jagx-20201231x10k003.jpg GRAPHIC 35381
  Complete submission text file 0001558370-21-003811.txt   16590783

Data Files

Seq Description Document Type Size
10 EX-101.INS jagx-20201231.xml EX-101.INS 2780760
11 EX-101.SCH jagx-20201231.xsd EX-101.SCH 166616
12 EX-101.CAL jagx-20201231_cal.xml EX-101.CAL 90517
13 EX-101.DEF jagx-20201231_def.xml EX-101.DEF 777527
14 EX-101.LAB jagx-20201231_lab.xml EX-101.LAB 1170290
15 EX-101.PRE jagx-20201231_pre.xml EX-101.PRE 1047566
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36714 | Film No.: 21793081
SIC: 2834 Pharmaceutical Preparations